Cancer Pain Management Market Breakdown By Size, Share, Growth, Trends, and Industry 2030- MarkNtel Advisors

According to Markntel Advisors Report, Cancer Pain Management Market is expected to grow at a significant growth rate, and the analysis period is 2024-2030, considering the base year as 2023. Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.

Cancer pain management includes both the drugs & therapies provided to cancer patients by the healthcare facilities to provide relief from moderate to severe pain. Some of the major drugs that help in reducing pain include opioids and non-opioid medications like morphine, oxycodone, etc.

Global Cancer Pain Management Market Research Report & Summary:

The Global Cancer Pain Management Market is estimated to grow at a CAGR of around 5.60% during the forecast period, i.e., 2024-30.          

Time Period Captured in the Report:

·         Historical Years: 2019-22

·         Base Years: 2023

·         Forecast Years: 2024-2030

Who are the Key Players Operating in the Cancer Pain Management Market?

The top companies of the Cancer Pain Management Market ruling the industry are: 

Daiichi Sankyo Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals, Inc., Lupin, Forte Bio-Pharma LLC, Mallinckrodt Pharmaceuticals, Collegium Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Napp Pharmaceuticals, Zentiva Group, Mundipharma International, G.L. Pharma, and Others.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report. 

Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/cancer-pain-management-market.html

("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")

Cancer Pain Management Industry Recent Development:

·         2022: Strides Pharma received the US Food and Drug Administration approval for Ibuprofen suspension, a nonsteroidal anti-inflammatory drug (NSAID) used as a painkiller.

The Cancer Pain Management Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic.  The further bifurcations are as follows:

-By Drug Class

-Opioids- Market Size & Forecast 2019-2030, USD Million

-Morphine- Market Size & Forecast 2019-2030, USD Million

-Oxycodone- Market Size & Forecast 2019-2030, USD Million

-Fentanyl- Market Size & Forecast 2019-2030, USD Million

-Others (Methadone, Tapentadol, etc.)- Market Size & Forecast 2019-2030, USD Million

-Non-Opioids- Market Size & Forecast 2019-2030, USD Million

-Acetaminophen- Market Size & Forecast 2019-2030, USD Million

-Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)- Market Size & Forecast 2019-2030, USD Million

-Ibuprofen- Market Size & Forecast 2019-2030, USD Million

-Naproxen- Market Size & Forecast 2019-2030, USD Million

-Others (Diclofenac, Ketorolac, etc.) - Market Size & Forecast 2019-2030, USD Million

-Antidepressants- Market Size & Forecast 2019-2030, USD Million

-Others (Steroids, Anti-convulsants, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Route of Administration

-Oral- Market Size & Forecast 2019-2030, USD Million

-Injectable- Market Size & Forecast 2019-2030, USD Million

-Transdermal- Market Size & Forecast 2019-2030, USD Million

-Others (Intranasal, Intrathecal, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Cancer Type

-Lung Cancer- Market Size & Forecast 2019-2030, USD Million

-Breast Cancer- Market Size & Forecast 2019-2030, USD Million

-Stomach- Market Size & Forecast 2019-2030, USD Million

-Colorectal- Market Size & Forecast 2019-2030, USD Million

-Others (Blood Cancer, Prostate Cancer, etc.)- Market Size & Forecast 2019-2030, USD Million)

-By Distribution Channel

-Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million

-Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million

-Online Pharmacies- Market Size & Forecast 2019-2030, USD Million

- By End User

-Hospitals- Market Size & Forecast 2019-2030, USD Million

-Homecare- Market Size & Forecast 2019-2030, USD Million

-Specialty Clinics- Market Size & Forecast 2019-2030, USD Million

-Others (Research Organisations, Palliative Care Centers, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Region

-North America

-South America

-Europe

-The Middle East & Africa

-Asia-Pacific

Access The Full report: https://www.marknteladvisors.com/research-library/cancer-pain-management-market.html

Market Dynamics -Global Cancer Pain Management Market:

Mounting Cancer Cases Across the Globe Elevating Market Growth – Over the past few years, there has been a surge in cancer cases in regions like North America, Latin America, etc. According to the research conducted by the Global Cancer Observatory, in 2022, the number of new cancer cases reached about 20.1 million. These cancer patients experience headaches & body pain. Therefore, health practitioners prescribe the patients the necessary cancer pain management drugs. Hence, the surging cancer cases across the globe are elevating the requirement for cancer pain management solutions, driving the Global Cancer Pain Management market.

In addition, cancer cases would continue to increase globally due to the growing geriatric population. As a result, the demand for cancer pain management solutions would continue to surge across the globe in the forecast period as well.

Adverse Side Effects of Opioid Medication Hampers the Market Growth – The patients suffering from cancer generally undergo treatment & take opioid medications. This medication helps in relieving cancer pain. However, the continuous usage of these drugs has negative impacts on the vital organs, which results in kidney or Organ failure. Therefore, cancer patients restrain themselves from opting for the high dosage of these drugs, resulting in lower sales of opioid cancer-related drugs. In addition, the continuous usage of these drugs results in addiction & depression, which is concerning for the patients. According to the study conducted by the American Medical Association (AMA), in 2022, around 3%-19% of total cancer patients develop an addiction to opioid medications. Therefore, health practitioners, restrain themselves from using these drugs and usually prefer alternative medicine to cope with cancer pain. This is resulting in a slowdown in the demand for opioid medication, hampering the Global Cancer Management market.

Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/cancer-pain-management-market.html

Why Markntel Advisor Report?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Further Queries:

Contact Us

MarkNtel Advisors

Call us - +1 628 895 8081, +91 120 4278433

Email at -sales@marknteladvisors.com

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India